Access in all areas? A round up of developments in market access and health technology assessment: part 3
In this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, and, fi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2024-02-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: |
| _version_ | 1797258468994842624 |
|---|---|
| author | Alice Beattie Catrin Treharne Sreeram V Ramagopalan |
| author_facet | Alice Beattie Catrin Treharne Sreeram V Ramagopalan |
| author_sort | Alice Beattie |
| collection | DOAJ |
| description | In this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, and, finally, the new Institute for Clinical and Economic Review (ICER) value assessment framework in the USA. |
| first_indexed | 2024-04-24T22:54:01Z |
| format | Article |
| id | doaj.art-afc97ac51a8b48b398a9a27ebcce3c5c |
| institution | Directory Open Access Journal |
| issn | 2042-6313 |
| language | English |
| last_indexed | 2024-04-24T22:54:01Z |
| publishDate | 2024-02-01 |
| publisher | Becaris Publishing Limited |
| record_format | Article |
| series | Journal of Comparative Effectiveness Research |
| spelling | doaj.art-afc97ac51a8b48b398a9a27ebcce3c5c2024-03-18T09:35:20ZengBecaris Publishing LimitedJournal of Comparative Effectiveness Research2042-63132024-02-0113310.57264/cer-2024-0009Access in all areas? A round up of developments in market access and health technology assessment: part 3Alice Beattie0Catrin Treharne1Sreeram V Ramagopalan2Lane Clark & Peacock LLP, London, W1U 1DQ, UKLane Clark & Peacock LLP, London, W1U 1DQ, UKLane Clark & Peacock LLP, London, W1U 1DQ, UK; Centre for Pharmaceutical Medicine Research, King’s College London, London, SE1 9NH, UKIn this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, and, finally, the new Institute for Clinical and Economic Review (ICER) value assessment framework in the USA.canadian drug agencydirect access schemehealth technology assessmenthealth technology managementicerinnovative medicines fundmarket accessvalue assessment frameworkvpag |
| spellingShingle | Alice Beattie Catrin Treharne Sreeram V Ramagopalan Access in all areas? A round up of developments in market access and health technology assessment: part 3 Journal of Comparative Effectiveness Research canadian drug agency direct access scheme health technology assessment health technology management icer innovative medicines fund market access value assessment framework vpag |
| title | Access in all areas? A round up of developments in market access and health technology assessment: part 3 |
| title_full | Access in all areas? A round up of developments in market access and health technology assessment: part 3 |
| title_fullStr | Access in all areas? A round up of developments in market access and health technology assessment: part 3 |
| title_full_unstemmed | Access in all areas? A round up of developments in market access and health technology assessment: part 3 |
| title_short | Access in all areas? A round up of developments in market access and health technology assessment: part 3 |
| title_sort | access in all areas a round up of developments in market access and health technology assessment part 3 |
| topic | canadian drug agency direct access scheme health technology assessment health technology management icer innovative medicines fund market access value assessment framework vpag |
| work_keys_str_mv | AT alicebeattie accessinallareasaroundupofdevelopmentsinmarketaccessandhealthtechnologyassessmentpart3 AT catrintreharne accessinallareasaroundupofdevelopmentsinmarketaccessandhealthtechnologyassessmentpart3 AT sreeramvramagopalan accessinallareasaroundupofdevelopmentsinmarketaccessandhealthtechnologyassessmentpart3 |